Baltimore medical device startup Sisu Global Health raises $1.2 million – Baltimore Business Journal
Baltimore’s Sisu Global Health Inc. is launching overseas sales of its first medical device with the help of $1.2 million in new funding.
Rockville-based Supernus Pharmaceuticals Inc. has reached a deal to acquire Miami-based Biscayne Neurotherapeutics in a deal worth up to $185 million.
Technologies such as cloud, bigdata, nosql databases, mobile apps, wearable sensors, and healthcare data interoperability are buzz words to many, but they are technologies that are propelling the healthcare-IT field forward into new frontiers. The possibilities these technologies bring can aide in patient engagement, data aggregation, integration and analytics for precision medicine. This is the cutting-edge space that Jeeva Informatics, a local company, operates in. It’s also a very attractive field for students who are eager to get work experience in the emerging technologies of the future.
There’s still no official word on where Amazon is planning to build its second headquarters, but a trail of clues may be leading to the Washington, D.C. area.
UBS expects London to lose at least 25% of its euro clearing volumes as a result of Brexit and thinks the losses could be even greater in the event of a disruptive exit from the EU.
Cybersecurity influencers believe that a new wave of system-embedded devices present a formidable challenge to their field. The Internet of Things (IoT) will introduce a vast amount of small computers, with inadequate security designs, that use high-speed internet, and that combination has all the ingredients for a cyberspace disaster.
Bob Stratton, a security entrepreneur and consultant, states that not every device has to have the high-level security of desktop computers, but manufactures of small computers should include a built-in level of resistance and system integrity.
ExeGi Pharma is pleased to announce two new clinical partnerships with the College of Veterinary Medicine at the University of Georgia and the University of Tennessee to study the Visbiome Vet probiotic in domestic dogs. Both studies will evaluate the probiotic’s effectiveness in managing canine gastrointestinal disorders. Visbiome Vet is an 8-strain probiotic compound with an extremely high concentration of beneficial bacteria (112.5 billion bacteria per dose). The formulation in Visbiome Vet is one of the most extensively studied probiotic products for pets, as it has been the subject of four controlled clinical trials.
Press Announcements > FDA awards five grants to advance the development of pediatric medical devices
The U.S. Food and Drug Administration announced today that it has awarded five grants totaling up to $6 million per year over the next five years to Pediatric Device Consortia (PDC) across the country that will provide advice and support services to innovators of children’s medical devices. The program aims to enhance the development, production and distribution of pediatric medical devices and has awarded $37 million to various consortia since 2009.
Enjoy an evening with food, fun and lively conversation at Biotech and Beer. Meet old friends and new colleagues in the life science community. Complimentary admission for any bioscience company employees, and university students and researchers with advanced registration. All others may purchase tickets.
When: Thursday, Septmember 27, 2018 4:00-7:00 PM
Where: Farm Brew Live 9901 Discovery Blvd. Manassas, Virginia 20109 United States
Biopharmaceutical, biotech and medical technology companies comprise one of the state’s strongest sectors. They’re crucial to generating new jobs, products and services